Literature DB >> 16237767

Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors.

Christian Toso1, Pietro Majno, Axel Andres, Laura Rubbia-Brandt, Thierry Berney, Léo Buhler, Philippe Morel, Gilles Mentha.   

Abstract

AIM: While hepatocellular adenomas (HAs) have often been studied as a unique entity, we aimed to better define current management of the various forms of HAs.
METHODS: Twenty-five consecutive patients operated for solitary-uncomplicated (9), multiple (6), and ruptured (10) HAs were reviewed according to management strategies and outcomes.
RESULTS: All solitary-uncomplicated HAs (ranged 2.2-14 cm in size) were removed. Out of 25 HAs, 2 (8%) included foci of carcinoma. In the multiple HA group, previously undiagnosed tumors were identified during surgery in 5/6 cases. In three cases with multiple spread HA, several lesions had to be left unresected. They remained unmodified after 4-, 6-, and 6-year radiological follow-up. Patients with ruptured HA (ranged 1.7-10 cm in size) were initially managed with hemodynamic support and angiography, allowing the embolization of actively bleeding tumors in two patients. All ruptured tumors were subsequently removed 5.5 d (range 4-70 d) after admission.
CONCLUSION: Tumors suspected of HA, regardless of the size, should be resected, because of high chances of rupture causing bleeding, and/or containing malignant foci. Although it is desirable to remove all lesions of multiple HA, this may not be possible in some patients, for whom long-term radiological follow-up is advised. Ruptured HA can be managed by hemodynamic support and angiography, allowing scheduled surgery.

Entities:  

Mesh:

Year:  2005        PMID: 16237767      PMCID: PMC4481490          DOI: 10.3748/wjg.v11.i36.5691

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

Review 1.  Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature.

Authors:  L Chiche; T Dao; E Salamé; M P Galais; N Bouvard; G Schmutz; P Rousselot; P Bioulac-Sage; P Ségol; M Gignoux
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Disappearance of liver cell adenoma: CT and MR imaging.

Authors:  M Kawakatsu; V Vilgrain; S Erlinger; H Nahum
Journal:  Abdom Imaging       Date:  1997 May-Jun

3.  Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit.

Authors:  T Leese; O Farges; H Bismuth
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

4.  Laparoscopic management of benign solid and cystic lesions of the liver.

Authors:  N Katkhouda; M Hurwitz; J Gugenheim; E Mavor; R J Mason; D J Waldrep; R T Rivera; M Chandra; G M Campos; S Offerman; A Trussler; P Fabiani; J Mouiel
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

Review 5.  Management of focal nodular hyperplasia and hepatocellular adenoma.

Authors:  G Mentha; L Rubbia-Brandt; N Howarth; P Majno; P Morel; F Terrier
Journal:  Swiss Surg       Date:  1999

6.  Treatment of ruptured hepatocellular adenoma.

Authors:  T Terkivatan; J H de Wilt; R A de Man; R R van Rijn; H W Tilanus; J N IJzermans
Journal:  Br J Surg       Date:  2001-02       Impact factor: 6.939

Review 7.  Hepatic adenoma and focal nodular hyperplasia.

Authors:  C K Shortell; S I Schwartz
Journal:  Surg Gynecol Obstet       Date:  1991-11

8.  Benign liver tumors: differential diagnosis and indications for surgery.

Authors:  A Weimann; B Ringe; J Klempnauer; P Lamesch; K F Gratz; M Prokop; H Maschek; G Tusch; R Pichlmayr
Journal:  World J Surg       Date:  1997 Nov-Dec       Impact factor: 3.352

9.  Hepatic adenoma: MR findings in 51 pathologically proved lesions.

Authors:  L Arrivé; J F Fléjou; V Vilgrain; J Belghiti; D Najmark; M Zins; Y Menu; J M Tubiana; H Nahum
Journal:  Radiology       Date:  1994-11       Impact factor: 11.105

10.  Resection of presumed benign liver tumours.

Authors:  J Belghiti; D Pateron; Y Panis; V Vilgrain; J F Fléjou; J P Benhamou; F Fékété
Journal:  Br J Surg       Date:  1993-03       Impact factor: 6.939

View more
  8 in total

1.  Regarding 'Liver cell adenoma and liver cell adenomatosis' by Ludger Barthelmes and Iain S. Tait.

Authors:  Niels F M Kok; Türkan Terkivatan; Jan N M Ijzermans
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

2.  Malignant transformation of hepatocellular adenoma: how frequently does it happen?

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

3.  European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group.

Authors:  Alexis Laurent; Safi Dokmak; Jean-Charles Nault; François-René Pruvot; Jean-Michel Fabre; Christian Letoublon; Philippe Bachellier; Lorenzo Capussotti; Olivier Farges; Jean-Yves Mabrut; Yves-Patrice Le Treut; Ahmet Ayav; Bertrand Suc; Olivier Soubrane; Gilles Mentha; Irinel Popescu; Marco Montorsi; Nicolas Demartines; Jacques Belghiti; Guido Torzilli; Daniel Cherqui; Jean Hardwigsen
Journal:  HPB (Oxford)       Date:  2016-07-22       Impact factor: 3.647

Review 4.  Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases.

Authors:  Jan H M B Stoot; Robert J S Coelen; Mechteld C De Jong; Cornelis H C Dejong
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

5.  Giant hepatic adenoma with bone marrow metaplasia not associated with oral contraceptive intake.

Authors:  Giovanni Ramacciato; Giuseppe R Nigri; Paolo Aurello; Francesco D'Angelo; Francesca Pezzoli; Simone Rossi; Emanuela Pilozzi; Giorgio Ercolani; Matteo Ravaioli
Journal:  World J Surg Oncol       Date:  2006-08-25       Impact factor: 2.754

Review 6.  Hepatocellular adenoma: when and how to treat? Update of current evidence.

Authors:  Maarten G Thomeer; Mirelle Broker; Joanne Verheij; Michael Doukas; Turkan Terkivatan; Diederick Bijdevaate; Robert A De Man; Adriaan Moelker; Jan N IJzermans
Journal:  Therap Adv Gastroenterol       Date:  2016-09-28       Impact factor: 4.409

7.  Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification.

Authors:  Charles Balabaud; Wesal R Al-Rabih; Pei-Jer Chen; Kimberley Evason; Linda Ferrell; Juan C Hernandez-Prera; Shiu-Feng Huang; Thomas Longerich; Young Nyun Park; Alberto Quaglia; Peter Schirmacher; Christine Sempoux; Swan N Thung; Michael Torbenson; Aileen Wee; Matthew M Yeh; Shiou-Hwei Yeh; Brigitte Le Bail; Jessica Zucman-Rossi; Paulette Bioulac-Sage
Journal:  Int J Hepatol       Date:  2013-04-14

8.  The management of pregnancy in women with hepatocellular adenoma: a plea for an individualized approach.

Authors:  Mirelle E E Bröker; Jan N M Ijzermans; Susanna M van Aalten; Robert A de Man; Türkan Terkivatan
Journal:  Int J Hepatol       Date:  2012-12-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.